Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomised trial

Lancet

Volumn 355, Issue 9215, 2000, Pages 1588-1596

  Gray, R G ^a   Kerr, D J ^a   McConkey, C C ^a   Williams, N S ^a   Hills, R K ^a  

^a Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; ANTINEOPLASTIC ANTIMETABOLITE; IMMUNOLOGICAL ADJUVANT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; STOMATITIS; VOMITING; ADJUVANT THERAPY; COLON TUMOR; COMPARATIVE STUDY; DRUG COMBINATION; RECTUM TUMOR; SURVIVAL; TUMOR RECURRENCE;

ADJUVANTS, IMMUNOLOGIC; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DRUG THERAPY, COMBINATION; FLUOROURACIL; HUMANS; LEUCOVORIN; LEVAMISOLE; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0034611854     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02214-5     Document Type: Article

References (30)

1. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality of twenty-five major cancers in 1990. Int J Cancer. 83:1999;18-29.
2. Moertel C.G., Fleming T.R., Macdonald J.S.et al. Levamisole and fluorouracil as adjuvant therapy of resected colon carcinoma. N Engl J Med. 322:1990;352-358.
3. Cancer of the colon and rectum consensus statement. Br J Surg. 77:1990;1063-1065.
4. NIH Consensus Conference: adjuvant cancer therapy. JAMA 1990; 264: 1444-50.
5. Slevin M., Gray R.G. Adjuvant therapy for cancer of the colon. an important step forward BMJ. 302:1991;1100-1101.
6. Arnaud J.P., Buyse M., Nordlinger B.et al. Adjuvant therapy of poor prognosis colon cancer with levamisole. results of an EORTC double-blind randomized clinical trial Br J Surg. 76:1989;284-289.
7. Bandealy M.T., Gonin R., Loehrer P.J.et al. Prospective randomised trial of 5-fluorouracil versus 5 fluorouracil plus levamisole in the treatment of metastatic colorectal cancer. A Hoosier Oncology Group Trial Clin Cancer Res. 4:1998;935-939.
8. Francini G., Petrioli R., Lorenzini L.et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology. 106:1994;899-906.
9. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet. 345:1995;939-944.
10. O'Connell M., Mailliard J., Kahn M.J.et al. Control trial of fluorouracil and low-dose leucovorin given for six months as post-operative adjuvant therapy for colon cancer. J Clin Oncol. 15:1997;246-250.
11. Wolmark N., Rockette H., Fisher B.et al. The benefit of leucovorin modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer. results from National Surgical Adjuvant Breast and Bowel Project protocol C-03 J Clin Oncol. 11:1993;1879-1887.
12. Kerr D.J. 5-fluorouracil and folinic acid. interesting biochemistry or effective treatment? Br J Cancer. 60:1989;807-808.
13. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol. 10:1992;896-903.
14. Zittoun J., Marquet J., Pilkorger J.J.et al. Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and modulation of 5-fluorouracil. Br J Cancer. 63:1991;885-888.
15. Expert report on the clinical documentation of l-folinic acid for USA registration file. American Cyanamid Company-Lederle International (data on file).
16. Pahlman L., Glimelius B. Pre- or post-operative radiotherapy in rectal and rectosigmoid carcinoma. report from a randomised multicentre trial Ann Surg. 211:1989;187-195.
17. Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer, vol 1, worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990.
18. Jäger E., Heike M., Klein O.et al. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer. results of a randomized multi-center trial J Clin Oncol. 14:1996;2274-2279.
19. Petrelli N., Douglass H.O., Herrera L.et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma. a prospective randomised phase III trial J Clin Oncol. 7:1989;1419-1426.
20. Ychou M., Fabbro-Peray P., Perney P.et al. A prospective randomised study comparing high and low-dose leucovorin combined with same dose 5- fluorouracil in advanced colorectal cancer. Am J Clin Oncol. 21:1998;233-236.
21. Wolmark N., Rockette H., Mamounas E.et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole and fluorouracil, leucovorin, and levamisole in patients with Dukes B and C carcinoma of the colon. results from National Surgical Adjuvant Breast and Bowel Project C-04 J Clin Oncol. 17:1999;3553-3559.
22. Haller D.G., Catalano P.J., MacDonald J.S.et al. Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: five-year final report of INT-0089. Proc Am Soc Clin Oncol. 17:1998;256. (abstr 982).
23. Cascinu S, Catalano V, Latini L, et al, on behalf of 'Colon Adiuvante Marche'. A randomized trial of adjuvant therapy of stage III colon cancer: levamisole and 5-fluorouracil versus 5-fluorouracil alone. Proc Am Soc Clin Oncol 1999 (A923).
24. Zoetmulder FAN, Taal BG, van Tinteren H, on behalf of the NACCP. Adjuvant 5FU plus levamisole improves survival in stage II and III colonic cancer, but not in rectal cancer. interim analysis of the Netherlands Adjuvant Colorectal Cancer Project (NACCP). Proc Am Soc Clin Oncol 1999 (A1021).
25. Zalcberg J.R., Siderov J., Simes J. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol. 7:1996;41-46.
26. O'Connell M.J., Laurie J.A., Kahn M.et al. Prospectively randomised trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 16:1998;295-300.
27. Peto R. Monitoring cancer patients in clinical trials need not be precise. Symington T., Williams A.E., McVie H.G. Cancer assessment and monitoring. 1980;377-381 Churchill Livingstone, Edinburgh.
28. Collins R., Peto R., Gray R., Parish S. Large-scale randomized evidence: trials and overviews. Weatherall D., Ledingham J.G.G., Warrell D.A. Oxford textbook of medicine, vol 1. 1996;21-32 Oxford University Press, Oxford.
29. Improving outcomes in colon cancer: the research evidence. 1997;NHS Executive, Department of Health, London.
30. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol. 17:1999;1356-1363.